Home
Tarsus Pharmaceuticals TARS paid Forbes-Tate $50K for lobbying in Q1 2026 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q1 2026
- Client
- Tarsus Pharmaceuticals
- Reported
- 26/04/19
Up 0.0% from last quarter
What else happened in Tarsus Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 03/01~04/30Tarsus Pharmaceuticals's other lobbying reports
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 07/20
for Q2
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 01/17
for Q4 2025
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 25/10/18
for Q3 2025
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 25/07/17
for Q2 2025
- Tarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
LobbyingTarsus Pharmaceuticals
TARS
$50K
$50K
Reported 25/04/21
for Q1 2025